Le Lézard
Classified in: Health
Subjects: TDS, FVT

Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference


SUNNYVALE, Calif., Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. The management team is scheduled to participate in a Fireside Chat on Thursday, February 18th at 12:30 pm PACIFIC / 3:30 pm EASTERN. A live webcast can be accessed on the Accuray website at https://investors.accuray.com/

This invitation-only conference will bring together more than 100 corporate management teams with BTIG's institutional investor clients. Leveraging BTIG's extensive global network and insight into the healthcare space, the conference attracts some of the industry's most innovative companies and helps connect them with institutional investors to discuss investment opportunities and sector trends.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases?while making commonly treatable cases even easier?to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.

Investor Contact
Joe Diaz
Investor Relations - Accuray
Tel: +1 (602) 717-7804
E-mail: [email protected]

Media Contact
Beth Kaplan
Public Relations Director - Accuray
Tel: +1 (408) 789-4426
E-mail: [email protected]

SOURCE Accuray Incorporated


These press releases may also interest you

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

16 mai 2024
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

16 mai 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...



News published on and distributed by: